Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Investigation on the chemical space of the substituted triazole thio-benzoxazepinone RIPK1 inhibitors
Yanan Hao, Hongming Shao, Zhuo Qu, et al.
European Journal of Medicinal Chemistry (2022) Vol. 236, pp. 114345-114345
Closed Access | Times Cited: 13

Showing 13 citing articles:

RIPK1 inhibitors: A key to unlocking the potential of necroptosis in drug development
Yinliang Bai, Yujun Qiao, Mingming Li, et al.
European Journal of Medicinal Chemistry (2024) Vol. 265, pp. 116123-116123
Closed Access | Times Cited: 14
Targeting Receptor-Interacting Protein Kinase 1 by Novel Benzothiazole Derivatives: Treatment of Acute Lung Injury through the Necroptosis Pathway
Xinqi Zhang, Qianyu Han, Ruilin Hou, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 7, pp. 5261-5278
Closed Access | Times Cited: 13
Discovery of a novel quinoline RIP1 inhibitor and its treatment of acute liver injury in mice
Bin Xu, Linghui Yang, Ruiqi Jiang, et al.
Bioorganic Chemistry (2025) Vol. 159, pp. 108365-108365
Closed Access
Discovery and Characterization of Novel Receptor-Interacting Protein Kinase 1 Inhibitors Using Deep Learning and Virtual Screening
Bo Liu, Likun Zhao, Ying Tan, et al.
ACS Chemical Neuroscience (2025)
Closed Access
Discovery of a Trifluoromethoxy Cyclopentanone Benzothiazole Receptor-Interacting Protein Kinase 1 Inhibitor as the Treatment for Alzheimer’s Disease
Yi Sun, Lijuan Xu, Hongming Shao, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 21, pp. 14957-14969
Closed Access | Times Cited: 17
Receptor-interacting protein kinase 1 (RIPK1) inhibitor: a review of the patent literature (2018-present)
Lijuan Xu, Wannian Zhang, Chunlin Zhuang
Expert Opinion on Therapeutic Patents (2023) Vol. 33, Iss. 2, pp. 101-124
Closed Access | Times Cited: 10
Structure-Based Design of Novel Alkynyl Thio-Benzoxazepinone Receptor-Interacting Protein Kinase-1 Inhibitors: Extending the Chemical Space from the Allosteric to ATP Binding Pockets
Danni Quan, Ruilin Hou, Hongming Shao, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 4, pp. 3073-3087
Closed Access | Times Cited: 6
Insight from Linker Investigations: Discovery of a Novel Phenylbenzothiazole Necroptosis Inhibitor Targeting Receptor-Interacting Protein Kinase 1 (RIPK1) from a Phenoxybenzothiazole Compound with Dual RIPK1/3 Targeting Activity
Jingjie Fang, Houzong Yao, Chunlin Zhuang, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 22, pp. 15288-15308
Closed Access | Times Cited: 5
Discovery of novel biaryl benzoxazepinones as dual-mode receptor-interacting protein kinase-1 (RIPK1) inhibitors
Y.‐C. XIN, Pengcheng Dai, Hongming Shao, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 100, pp. 117611-117611
Closed Access | Times Cited: 1
Profiling of the chemical space on the phenyl group of substituted benzothiazole RIPK3 inhibitors
Yue Xu, Caiquan Liang, Wannian Zhang, et al.
Bioorganic Chemistry (2022) Vol. 131, pp. 106339-106339
Closed Access | Times Cited: 7
Discovery of Sibiriline derivatives as novel receptor-interacting protein kinase 1 inhibitors
Ningjie Cui, Shang Li, Yonglei Zhang, et al.
European Journal of Medicinal Chemistry (2023) Vol. 250, pp. 115190-115190
Closed Access | Times Cited: 3
Discovery of a Novel Benzimidazole Necroptosis Inhibitor from an In-House Compound Library
Yu Zou, Chai Yue, Hongming Shao, et al.
Pharmaceutical Fronts (2024) Vol. 06, Iss. 03, pp. e283-e293
Open Access
Discovery of 4-amino-1,6-dihydro-7H-pyrrolo[2,3-d]pyridazin-7-one derivatives as potential receptor-interacting serine/threonine-protein kinase 1 (RIPK1) inhibitors
Chufeng Zhang, Yulian Chen, Yong Li, et al.
European Journal of Medicinal Chemistry (2023) Vol. 265, pp. 116076-116076
Closed Access | Times Cited: 1
Page 1

Scroll to top